Inventor
ARLEN MYRON
US15 patents
⚠️ This page may combine multiple inventors who share the name “ARLEN MYRON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PREC BIOLOGICS INC
6 patentsUS10364295B2Jul 30, 2019
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
PREC BIOLOGICS INC3 citations82
US9605077B2Mar 28, 2017
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
PREC BIOLOGICS INC5 citations82
US9592290B2Mar 14, 2017
Monoclonal antibody therapy for pancreas cancer
PREC BIOLOGICS INC5 citations82
US11572413B2Feb 7, 2023
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
PREC BIOLOGICS INC1 citations71
US11001641B2May 11, 2021
Monoclonal antibody therapy for pancreas cancer
PREC BIOLOGICS INC1 citations71
US12460013B2Nov 4, 2025
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
PREC BIOLOGICS INC0 citations60
ARLEN MYRON
4 patentsUS8470326B2Jun 25, 2013
Monoclonal antibody therapy for pancreas cancer
ARLEN MYRON11 citations90
US9169326B2Oct 27, 2015
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
ARLEN MYRON7 citations82
US9034588B2May 19, 2015
Monoclonal antibody therapy for pancreas cancer
ARLEN MYRON11 citations82
US8535667B2Sep 17, 2013
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
ARLEN MYRON8 citations82
NEOGENIX ONCOLOGY INC
2 patentsUS7314622B2Jan 1, 2008
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
NEOGENIX ONCOLOGY INC111 citations96
US7763720B2Jul 27, 2010
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
NEOGENIX ONCOLOGY INC18 citations88